Payment overview · 2025
General Payments
$22.64
1 reported records · 1 companies
Healthcare provider profile · identity verified
Idania Martinez, APRN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · HIALEAH, FL · NPI 1114583218
Verified facts
What the public records show
CMS Open Payments records show Idania Martinez, APRN received $22.64 in general payments during 2025 across 1 reported records.
Biogen, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Biogen, Inc. | Unresolved — no canonical attribution shown | $22.64 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $22.64 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| PLEGRIDY Normalized: plegridy |
Biological | Biogen, Inc. | $22.64 | 1 | 2025 |
Source payment records
|
|||||
| TYSABRI Normalized: tysabri |
Biological | Biogen, Inc. | $22.64 | 1 | 2025 |
Source payment records
|
|||||
| VUMERITY Normalized: vumerity |
Drug | Biogen, Inc. | $22.64 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1663 | 362 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 1136 | 258 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 744 | 134 |
| Metoprolol Succinate | Metoprolol Succinate | 687 | 151 |
| Metformin Hcl | Metformin Hcl | 587 | 120 |
| Amlodipine Besylate | Amlodipine Besylate | 486 | 112 |
| Levothyroxine Sodium | Levothyroxine Sodium | 476 | 89 |
| Losartan Potassium | Losartan Potassium | 448 | 98 |
| Gabapentin | Gabapentin | 423 | 97 |
| Lisinopril | Lisinopril | 415 | 91 |
| Memantine Hcl | Memantine Hcl | 395 | 83 |
| Tamsulosin Hcl | Tamsulosin Hcl | 380 | 87 |
| Pantoprazole Sodium | Pantoprazole Sodium | 333 | 86 |
| Folic Acid | Folic Acid | 327 | 71 |
| Nifedipine Er | Nifedipine | 295 | 62 |
| Irbesartan | Irbesartan | 262 | 49 |
| Omeprazole | Omeprazole | 254 | 83 |
| Latanoprost | Latanoprost | 250 | 58 |
| Glipizide Er | Glipizide | 232 | 46 |
| Trazodone Hcl | Trazodone Hcl | 219 | 54 |
| Atenolol | Atenolol | 218 | 41 |
| Ezetimibe | Ezetimibe | 214 | 49 |
| Donepezil Hcl | Donepezil Hcl | 204 | 42 |
| Glipizide | Glipizide | 200 | 41 |
| Escitalopram Oxalate | Escitalopram Oxalate | 193 | 41 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 173 | 43 |
| Alendronate Sodium | Alendronate Sodium | 171 | 39 |
| Montelukast Sodium | Montelukast Sodium | 169 | 36 |
| Clopidogrel | Clopidogrel Bisulfate | 153 | 42 |
| Metoprolol Tartrate | Metoprolol Tartrate | 147 | 31 |
| Hydrochlorothiazide | Hydrochlorothiazide | 138 | 35 |
| Famotidine | Famotidine | 133 | 47 |
| Duloxetine Hcl | Duloxetine Hcl | 116 | 29 |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 112 | 29 |
| Finasteride | Finasteride | 102 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 101 | 41 |
| Enalapril Maleate | Enalapril Maleate | 101 | 18 |
| Carvedilol | Carvedilol | 96 | 31 |
| Mirtazapine | Mirtazapine | 89 | 25 |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 82 | 18 |
| Quetiapine Fumarate | Quetiapine Fumarate | 71 | 16 |
| Temazepam | Temazepam | 71 | 19 |
| Celecoxib | Celecoxib | 69 | 59 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 69 | 21 |
| Pregabalin | Pregabalin | 68 | 17 |
| Pioglitazone Hcl | Pioglitazone Hcl | 65 | 21 |
| Eliquis | Apixaban | 64 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 62 | 18 |
| Xarelto | Rivaroxaban | 59 | 17 |
| Timolol Maleate | Timolol Maleate | 58 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 56 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 56 | 38 |
| Sucralfate | Sucralfate | 56 | 28 |
| Pentoxifylline | Pentoxifylline | 53 | 14 |
| Alprazolam | Alprazolam | 50 | 22 |
| Azithromycin | Azithromycin | 50 | 46 |
| Clonazepam | Clonazepam | 49 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 48 | 17 |
| Meloxicam | Meloxicam | 48 | 38 |
| Furosemide | Furosemide | 47 | 18 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 47 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 46 | 21 |
| Benzonatate | Benzonatate | 46 | 42 |
| Mupirocin | Mupirocin | 45 | 36 |
| Zolpidem Tartrate | Zolpidem Tartrate | 44 | suppressed |
| Acarbose | Acarbose | 43 | 11 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 43 | 30 |
| Meclizine Hcl | Meclizine Hcl | 42 | 30 |
| Chlorthalidone | Chlorthalidone | 41 | 12 |
| Labetalol Hcl | Labetalol Hcl | 40 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 40 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 39 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 39 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 39 | 35 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 37 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 37 | 20 |
| Prednisone | Prednisone | 36 | 19 |
| Ibuprofen | Ibuprofen | 32 | 20 |
| Levemir | Insulin Detemir | 32 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 32 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 31 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 31 | 29 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 31 | suppressed |
| Methylprednisolone | Methylprednisolone | 31 | 30 |
| Topiramate | Topiramate | 31 | suppressed |
| Unifine Pentips | Pen Needle, Diabetic | 31 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 29 | suppressed |
| Lumigan | Bimatoprost | 29 | suppressed |
| Glimepiride | Glimepiride | 28 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 27 | suppressed |
| Entresto | Sacubitril/Valsartan | 27 | suppressed |
| Spironolactone | Spironolactone | 27 | 13 |
| Buspirone Hcl | Buspirone Hcl | 26 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 26 | 26 |
| Cilostazol | Cilostazol | 25 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 25 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 25 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 25 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 25 | 11 |
| Amoxicillin | Amoxicillin | 24 | 21 |
| Brilinta | Ticagrelor | 24 | suppressed |
| Fenofibrate | Fenofibrate | 24 | suppressed |
| Methocarbamol | Methocarbamol | 24 | 18 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 23 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 23 | suppressed |
| Primidone | Primidone | 23 | suppressed |
| Comfort Ez Insulin Syringe | Syringe And Needle,insulin,1ml | 22 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 22 | 18 |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 22 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 21 | suppressed |
| Allopurinol | Allopurinol | 20 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 20 | suppressed |
| Calcitriol | Calcitriol | 20 | suppressed |
| Tadalafil | Tadalafil | 20 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | 17 |
| Benazepril Hcl | Benazepril Hcl | 19 | suppressed |
| Hydrocortisone | Hydrocortisone | 19 | 16 |
| Moxifloxacin | Moxifloxacin Hcl | 19 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 18 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | 12 |
| Warfarin Sodium | Warfarin Sodium | 18 | suppressed |
| Nabumetone | Nabumetone | 16 | 16 |
| Tramadol Hcl | Tramadol Hcl | 16 | 11 |
| Veo Insulin Syringe | Syringe And Needle,insulin,1ml | 16 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Levetiracetam | Levetiracetam | 15 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 15 | suppressed |
| Ciclopirox | Ciclopirox | 14 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 13 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | 12 |
| Nitroglycerin | Nitroglycerin | 13 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 13 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 13 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 12 | suppressed |
| Erythromycin | Erythromycin Base | 12 | 11 |
| Felodipine Er | Felodipine | 12 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 12 | suppressed |
| Travoprost | Travoprost | 12 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 11 | 11 |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | 11 |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Nystatin | Nystatin | 11 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $22.64 · 1 records | Biogen, Inc. | PLEGRIDY, TYSABRI, VUMERITY | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error